Amatheon Agri Receives Regulatory Approval to Cultivate Medical Cannabis in Zimbabwe

2y
3m read
Summary

Medical cannabis boom The legalisation of medical cannabis continues to gain momentum around the world. Among patients and healthcare professionals, there is an increasing awareness about the benefits of medical cannabis for a variety of ailments. The core concept of combining direct commercial farming with production by neighboring smallholder farmers (outgrowers) remains central to Amatheon Agri’s growth strategy. Constantino Chiwenga, who highlighted his appreciation of Amatheon Agri’s new investment initiative in the country. As a heavily regulated and extremely high value crop, this new product will further diversify Amatheon Agri’s export portfolio and spearhead its entry into the speciality products market.

Article Preview

BERLIN, GERMANY / ACCESSWIRE / June 14, 2021 / The Ministry of Health of Zimbabwe has approved Amatheon Agri’s license to produce cannabis for medical and scientific use

The company now embarks on an assessment and planning phase for growing and producing an assortment of cannabidiol (CBD) products

The global medical cannabis industry was estimated to be worth around US$21 billion in 2020, with very high estimated annual growth rates over the next five years as an increasing number of countries approve its use

Amatheon Agri’s subsidiary in Zimbabwe was established in 2014 and seeks a first-mover advantage as the...

Read the full article @ Cannabis Law Report